In Swedish
Put in for the test

News

New Board Member

Press release

M.Sc. Göran Beijer was elected as a new board member of Alertix at an extraordinary general meeting on the 17th of December 2019.

Read more

Support from Vinnova

Press release

More support for Alertix’ acclaimed research. This time from Sweden’s Innovation Agency Vinnova.

Read more

Alertix – Winner of the Innovation Award in Kalmar County

Press release

Today, Alertix received the innovation award SKAPA at a ceremony at the governor’s residence by the Governor Thomas Carlzon. Besides of the money-based award, Alertix will also be a participant in the national innovation award in November at Älvsjö, Sweden, when the Swedish master of innovation will be announced.

Read more

Alertix®  registered as trademark

Alertix®  is now registered as trademark both in Europe and internationally

Read more

Biomarkers to improve cancer care

At an international conference in Uppsala Sweden, Uppsala Health Summit 14-15 June 2018, professor Henrik Rönnberg, SLU Uppsala, co-organized a workshop named Towards Useful Cancer Biomarkers to Improve Cancer Care.

Read more

Technical advances offer new potential to TK1 as a tumor biomarker

A recently published review paper highlights TK1 as a tumor biomarker

Read more

Biomarkers to improve care for cancer

Today, at an international conference in Uppsala Sweden, Uppsala Health Summit 14-15 June 2018, professor Henrik Rönnberg, SLU Uppsala, co-organized a workshop named Towards Useful Cancer Biomarkers to Improve Cancer Care.

Read more

Henrik Rönnberg will lecture at the Nordic Small Animal Veterinary Conference

Oncology is the main theme of the BSA Congress of 2018, which will be arranged in Gothenburg at the end of January.
Alertix’ Henrik Rönnberg will be one of the lecturers. Henrik will, among other things, talk about new methods to treat cancer in animals.

Read more

Alertix homepage – now in English

Welcome to Alertix Veterinary Diagnostic’s international website .

Read more

Swedish research behind unique cancer test for pets

Press release

Cancer is just as common in companion animals as in humans. Cancer therapy is improving and in many cases the disease can be treated with success. However early diagnosis is crucial for successful treatment. Therefore, a new, unique cancer test can come to be of great significance.

Read more

Animal owners in favor of cancer test

One out of four responding animal owners are in favor of using a test for early detection of cancer in their pets. More than 40 percent are willing to pay equivalent to 70 USD or more of their own money for the test, and 50 percent might consider asking their veterinarian for a test.

Read more

Alertix Canine

Assay for early detection, monitoring and screening of tumor diseases in dogs. The assay is available to veterinary clinics and laboratories in Sweden and Scandinavia.
Read more about Alertix Canine

Alertix Feline

Assay for early detection, monitoring and screening of tumor diseases in cats. The assay is under development.
Read more about Alertix Feline
Under development

Alertix Equine

Assay for early detection, monitoring and screening of tumor diseases in horses. The assay is under development.
Under development
Read more about Alertix Equine

About cancer in companion animals

Did you know that our companion animals are afflicted by cancer as often as humans? Dogs and cats share not only our living environment but also our lifestyle. Because of this they are exposed to the same risk factors for cancer. Veterinary care is getting better and better at treating cancer in companion animals. But the crucial factor of success is that the disease is detected in time.

Read more about cancer in companion animals